Praxis Precision Medicines (PRAX) Return on Sales (2023 - 2025)
Praxis Precision Medicines has reported Return on Sales over the past 3 years, most recently at 39.28% for Q3 2025.
- Quarterly results put Return on Sales at 39.28% for Q3 2025, up 14892.0% from a year ago — trailing twelve months through Sep 2025 was 39.28% (up 6291.0% YoY), and the annual figure for FY2024 was 23.4%, up 2824.0%.
- Return on Sales for Q3 2025 was 39.28% at Praxis Precision Medicines, down from 34.98% in the prior quarter.
- Over the last five years, Return on Sales for PRAX hit a ceiling of 8.57% in Q4 2024 and a floor of 188.2% in Q3 2024.
- Median Return on Sales over the past 3 years was 53.99% (2023), compared with a mean of 64.63%.
- Biggest five-year swings in Return on Sales: crashed -13367bps in 2024 and later surged 14892bps in 2025.
- Praxis Precision Medicines' Return on Sales stood at 53.99% in 2023, then soared by 84bps to 8.57% in 2024, then plummeted by -358bps to 39.28% in 2025.
- The last three reported values for Return on Sales were 39.28% (Q3 2025), 34.98% (Q2 2025), and 28.69% (Q1 2025) per Business Quant data.